Cardiovascular outcomes and LDL-cholesterol levels in EMPA-REG OUTCOME(®)

OBJECTIVE: It is well established that higher low-density lipoprotein (LDL)-cholesterol levels are associated with increased cardiovascular risk. We analyzed whether effects of empagliflozin on cardiovascular outcomes varied by different LDL-cholesterol levels at baseline in EMPA-REG OUTCOME. METHOD...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Diab Vasc Dis Res
Huvudupphovsmän: Langslet, Gisle, Zinman, Bernard, Wanner, Christoph, Hantel, Stefan, Espadero, Rosa-Maria, Fitchett, David, Johansen, Odd Erik
Materialtyp: Artigo
Språk:Inglês
Publicerad: SAGE Publications 2020
Ämnen:
Brief Report
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7919220/
https://ncbi.nlm.nih.gov/pubmed/33307785
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1479164120975256
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk